K. Amaral

The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil

P. Picon, S. Artico, K. Amaral, 2012, BMC Infectious Diseases.

Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene

P. Picon, C. Niel, M. Fiegenbaum, 2013, Memorias do Instituto Oswaldo Cruz.

Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients

T. S. Gregianini, P. Picon, C. Niel, 2014, Memorias do Instituto Oswaldo Cruz.

Randomized clinical trial of a phytotherapic compound containing Pimpinella anisum, Foeniculum vulgare, Sambucus nigra, and Cassia augustifolia for chronic constipation

A. Henriques, P. Picon, R. Picon, 2010, BMC complementary and alternative medicine.

Prediction of Sustained Virological Response to Peginterferon-based Therapy for Chronic Hepatitis C: Regression Analysis of a Cohort from Rio Grande do Sul, Brazil

K. Amaral, L. Fendt, Rafael V Picon, 2017, Euroasian journal of hepato-gastroenterology.

Effectiveness of alpha interferon (+ ribavirin) in the treatment of chronic viral hepatitis C genotypes 2 and 3 in a Brazilian sample.

P. Picon, G. Sander, K. Amaral, 2012, Arquivos de gastroenterologia.

Treatment of hepatitis C with peginterferon and ribavirin in a public health program.

P. Picon, C. Tovo, A. A. de Mattos, 2009, Hepato-gastroenterology.